Literature DB >> 11395390

Myelin/axonal pathology in interleukin-12 induced serial relapses of experimental allergic encephalomyelitis in the Lewis rat.

Z Ahmed1, D Gveric, G Pryce, D Baker, J P Leonard, M L Cuzner, L T Diemel.   

Abstract

Lewis rats, on recovery from monophasic clinical experimental allergic encephalomyelitis (EAE), can be induced to develop repeated paralytic relapses with a graded reduction in clinical severity following intraperitoneal administration of IL-12. By the time of the third relapse, the number and size of inflammatory cuffs in the spinal cord were reduced with the makeup of the cellular infiltrate shifting to a significantly increased number of B cells. Serum levels of myelin basic protein (MBP)-specific IgG1 and IgG2b were found to rise over time while MBP and MBP peptide-positive macrophages and microglia became evident in perivascular cuffs and in spinal cord parenchyma, indicative of myelin phagocytosis. Axonal death was observed in semithin and EM sections of spinal cord in third relapse animals in association with iNOS and tPA immunostaining throughout gray and white matter. These neurotoxic or excitotoxic agents may contribute to axonal damage directly or indirectly by activated microglia and macrophages, leading to limited damage of the axonal-myelin unit.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11395390      PMCID: PMC1891982          DOI: 10.1016/s0002-9440(10)64684-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  55 in total

1.  Neuronal cell death and tPA.

Authors:  S E Tsirka; A D Rogove; S Strickland
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

2.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

3.  The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution.

Authors:  M L Cuzner; D Gveric; C Strand; A J Loughlin; L Paemen; G Opdenakker; J Newcombe
Journal:  J Neuropathol Exp Neurol       Date:  1996-12       Impact factor: 3.685

4.  Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine.

Authors:  A I Boullerne; K G Petry; M Meynard; M Geffard
Journal:  J Neuroimmunol       Date:  1995-07       Impact factor: 3.478

5.  Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator.

Authors:  A Gualandris; T E Jones; S Strickland; S E Tsirka
Journal:  J Neurosci       Date:  1996-04-01       Impact factor: 6.167

6.  IL-12 stimulates an antiviral type 1 cytokine response but lacks adjuvant activity in IFN-gamma-receptor-deficient mice.

Authors:  V E Schijns; B L Haagmans; M C Horzinek
Journal:  J Immunol       Date:  1995-09-01       Impact factor: 5.422

7.  Apoptosis of T cells and macrophages in the central nervous system of intact and adrenalectomized Lewis rats during experimental allergic encephalomyelitis.

Authors:  T Smith; M Schmied; A K Hewson; H Lassmann; M L Cuzner
Journal:  J Autoimmun       Date:  1996-04       Impact factor: 7.094

8.  Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator.

Authors:  S E Tsirka; A Gualandris; D G Amaral; S Strickland
Journal:  Nature       Date:  1995-09-28       Impact factor: 49.962

9.  Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis.

Authors:  Y Okuda; Y Nakatsuji; H Fujimura; H Esumi; T Ogura; T Yanagihara; S Sakoda
Journal:  J Neuroimmunol       Date:  1995-10       Impact factor: 3.478

10.  Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice.

Authors:  S D Wolf; B N Dittel; F Hardardottir; C A Janeway
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

View more
  7 in total

1.  Temporal pattern of plasma membrane calcium ATPase 2 expression in the spinal cord correlates with the course of clinical symptoms in two rodent models of autoimmune encephalomyelitis.

Authors:  Arnaud Nicot; Michael Kurnellas; Stella Elkabes
Journal:  Eur J Neurosci       Date:  2005-05       Impact factor: 3.386

2.  Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy.

Authors:  T Bucky Jones; D Michele Basso; Ajeet Sodhi; Jonathan Z Pan; Ronald P Hart; Robert C MacCallum; Sunhee Lee; Caroline C Whitacre; Phillip G Popovich
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

3.  Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.

Authors:  Yoh Matsumoto; Il-Kwon Park; Keiko Hiraki; Shin Ohtani; Kuniko Kohyama
Journal:  Immunology       Date:  2008-10-29       Impact factor: 7.397

4.  A role for caspase-1 and -3 in the pathology of experimental allergic encephalomyelitis : inflammation versus degeneration.

Authors:  Zubair Ahmed; Anne I Doward; Gareth Pryce; Deanna L Taylor; Jennifer M Pocock; John P Leonard; David Baker; M Louise Cuzner
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

5.  A role for the plasminogen activator system in inflammation and neurodegeneration in the central nervous system during experimental allergic encephalomyelitis.

Authors:  Emma East; David Baker; Gareth Pryce; H Roger Lijnen; M Louise Cuzner; Djordje Gverić
Journal:  Am J Pathol       Date:  2005-08       Impact factor: 4.307

6.  The contribution of the acute phase response to the pathogenesis of relapse in chronic-relapsing experimental autoimmune encephalitis models of multiple sclerosis.

Authors:  Silvy Mardiguian; Emma Ladds; Roberta Turner; Hazel Shepherd; Sandra J Campbell; Daniel C Anthony
Journal:  J Neuroinflammation       Date:  2017-09-30       Impact factor: 8.322

7.  NMR-Based Metabolomics Separates the Distinct Stages of Disease in a Chronic Relapsing Model of Multiple Sclerosis.

Authors:  Alex M Dickens; James R Larkin; Benjamin G Davis; Julian L Griffin; Timothy D W Claridge; Nicola R Sibson; Daniel C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-09       Impact factor: 4.147

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.